Poop pills to the rescue? trial tests fecal transplants for cancer treatment side effects
NCT ID NCT06218602
Summary
This study is testing if a fecal microbiota transplant (FMT) can help treat gut-related side effects caused by antibiotics in lymphoma patients receiving a powerful cell therapy called CAR-T. Researchers will give FMT to some participants and compare their side effects and treatment responses to others who receive the standard CAR-T therapy alone. The goal is to see if restoring healthy gut bacteria improves safety and outcomes for these patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.